Therapeutic Role and Immunogenic Characteristics of Cancer Testis Antigens in Breast Cancer: A Review

نویسندگان

1 Department of Genetics, Khuzestan Science and Research Branch, Islamic Azad University, Ahvaz, Iran

2 Department of Genetics, Ahvaz Branch, Islamic Azad University, Ahvaz, Iran

3 Noor-Gene Genetic Laboratory, Ahvaz, Iran

4 Lorestan University of Medical Sciences, Khorramabad, Iran

5 Department of Medical Genetics, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran

6 Pediatric Cell & Gene Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran

doi
10.22074/cellj.2026.2044248.1703
چکیده

Breast cancer remains a leading cause of cancer-related deaths among women globally, presenting significantchallenges due to its heterogeneity and complex biology. While traditional treatments such as surgery, chemotherapy,and targeted therapies offer some benefit, the lack of universal treatment strategies underscores the need for innovativeapproaches. A total of 255 articles were identified through PubMed, Scopus, Web of Science, and Google Scholar upto 1 December 2025, and 30 articles were selected for inclusion in this narrative review. This narrative review focuseson cancer-testis antigens (CTAs) as potential therapeutic targets in breast cancer. The objective of this narrativereview is to evaluate the therapeutic role and immunogenic characteristics of CTAs in breast cancer, with emphasis ontheir potential in diagnosis, prognosis, and immunotherapy. CTAs are tumor-associated antigens that are aberrantlyexpressed in various cancers, including breast cancer, while their expression in normal tissues is restricted to thetestis. Their unique immunogenic properties make them ideal candidates for both early diagnostic tools and targetedimmunotherapy. This article discusses the potential of CTAs in improving breast cancer screening, prognosis, andtreatment strategies, with particular emphasis on their roles in immunotherapy and vaccine development. Furthermore,the challenges of CTA-based treatments, including antigen heterogeneity and immune evasion, are outlined, along withinsights into future research directions aimed at overcoming these obstacles and improving clinical outcomes.

کلیدواژه‌ها